Cell Rh Rhesus Kell Duffy Kidd MNSs P Lewis Lu Results1 Results2 C D E c e Cw K k Kpa Fya Fyb Jka Jkb M N S s P1 Lea Leb Lua Gel
IATGel
IAT1 rr 0 0 0 + + 0 0 + 0 + 0 + 0 0 + + + +S + 0 0 0 w+ 2 rr 0 0 0 + + 0 0 + 0 0 + + 0 0 + + + +S + 0 0 0 0 3 rr 0 0 0 + + 0 0 + 0 + 0 0 + 0 + + 0 + 0 + 0 0 0 4 r"r 0 0 + + + 0 0 + 0 + + 0 + 0 + 0 + + + 0 0 0 0 5 R2R2 0 + + + 0 0 + 0 0 + 0 + 0 + 0 + 0 + 0 + 0 0 0 6 R2R2 0 + + + 0 0 + + 0 + + + 0 + 0 + 0 + 0 + 0 0 0 7 R1R1 + + 0 0 + 0 0 + 0 0 + + + + 0 + 0 +S 0 + + 0 0 8 R1R1 + + 0 0 + 0 0 + 0 0 + + 0 + 0 0 + + + 0 0 0 0 9 RZR1 + + + - + 0 + + 0 + 0 0 + + 0 0 + + + 0 0 0 w+ 10 r’r + 0 0 + + 0 0 + 0 + 0 + + + 0 + 0 +S 0 + 0 0 0 11 Auto 2+MFA 2+MFA Results1: Patient's post-transfusion plasma Results2: Patient's post-transfusion red cell eluate
NOTE: These tests were done using blood specimens drawn after the patient had been transfused with 2 units of O Rh negative RBC. The patient's plasma was also retested with the 6 RBC that tested positive before but they were now all negative by gel IAT.
Q #7. What can account for the patient's post-transfusion plasma giving negative panel results?
Q #8. Is an antibody identifiable using the patient's red cell eluate?
Q #9. If the physician had decided to continue transfusing the patient at this stage, what would you advise regarding the compatibility of such transfusions, all of which appear to be compatible in the crossmatch?
|
Copyright © 2002 - 2010, TraQ Program of the British Columbia Provincial Blood Coordinating Office, a program of the Provincial Health Services Authority. All rights reserved. |